ComViKin
Latest round
- Series B
Last raised
- Mar 2026
Total raised
- Undisclosed
Investors
- 10
About ComViKin
, trading under the name ComViKin, provides biosynthetic ingredients for the biotechnology and food industries. The company established an ester enzymatic synthesis process platform to achieve environmentally friendly production. In product application, the company has established joint laboratories with Tsinghua University, Jiangnan University, and other research institutions. The company works with enterprise clients across various industries to provide high-purity ingredients produced using biological enzymatic methods. Its core product is Ascorbyl Palmitate (AP), a fat-soluble antioxidant utilized in infant formula, cosmetics, and pharmaceutical preparations. The company generates revenue from the direct sale of its biosynthetic ingredients to global enterprise clients. The company plans to commercialize multiple new products through its technology platform, including enzymatically produced phytosterol esters, vitamin A palmitate, and ascorbyl oleate.
Who invested in ComViKin
10 investors across 2 rounds
See all investors in ComViKin
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ComViKin
Who invested in ComViKin?
ComViKin has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ComViKin raised?
ComViKin has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ComViKin last raise money?
ComViKin's most recent round on record is a Series B, in Mar 2026.
What does ComViKin do?
, trading under the name ComViKin, provides biosynthetic ingredients for the biotechnology and food industries.
Where is ComViKin headquartered?
ComViKin is headquartered in Huizhou, China.
Which VCs invest in companies like ComViKin?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at ComViKin's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ComViKin? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.